Japan· JP-2492418G1027
インスリングルリジン（遺伝子組換え）
A medicinal product containing インスリングルリジン（遺伝子組換え）, registered in Japan by サノフィ, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- インスリングルリジン（遺伝子組換え）
- Manufacturer
- サノフィ
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
インスリングルリジン（遺伝子組換え） in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAPIDRASanofi-Aventis Deutschland GmbH, Frankfurt am Main
- United KingdomApidra 100units/ml solution for injection 10ml vialsSanofi
- SpainAPIDRA 100 UNIDADES/ml OPTICLIK SOLUCION INYECTABLE EN CARTUCHOSanofi-Aventis Deutschland Gmbh
- FinlandApidraSanofi-Aventis Deutschland GmbH
- CanadaAPIDRASANOFI-AVENTIS CANADA INC
- IcelandApidraSanofi-Aventis Deutschland GmbH
- ItalyAPIDRA*1 flaconcino SC 10 ml 100 U/mlSANOFI AVENTIS DEUTSCHL.GMBH
- SwitzerlandApidra
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Apidra, Apidra Solostar
- Liechtenstein · Apidra, Apidra Solostar
- Norway · Apidra, Apidra Solostar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0ad7bf1a-0d23-44eb-9f84-c3f73a1c1c00 GET /v1/drugs/0ad7bf1a-0d23-44eb-9f84-c3f73a1c1c00?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "３００単位１キット",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2492418G1027",
"category": "注射薬",
"price_yen": 874,
"generic_name": "インスリングルリジン（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "2492",
"transitional_expiry": null
}See everything about インスリングルリジン（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.